We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
7 hedge funds and large institutions have $149K invested in Plus Therapeutics in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
27% more capital invested
Capital invested by funds: $117K → $149K (+$32K)
0% more funds holding
Funds holding: 7 → 7 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$42.3K |
| 2 |
VF
Virtu Financial
New York
|
+$31.7K |
| 3 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$5.28K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$5.28K |
Top Sellers
| 1 |
Barclays
London,
United Kingdom
|
-$26.4K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$5K |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$2K |